dieta para tirzepatide Mounjaro (tirzepatide) puede ser una herramienta útil dentro del tratamiento del sobrepeso y la obesidad, pero no reemplaza una alimentación adecuada ni la actividad física. El medicamento favorece la pérdida de peso Tirzepatida: la condición del nuevo

Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. The agency said the actions are intended to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The agency also emphasized ongoing concerns around promotional claims and direct-to-consumer messaging, building on the The FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025, the agency said

Single-digit weight loss

The researchers concluded that tirzepatide provided greater health benefits at lower costs, yielding an incremental cost-effectiveness ratio of $57,400 per quality-adjusted life year versus diet and exercise alone

Our clinic reflects those values, delivering individualized, clinically grounded weight loss and hormone care to patients who expect more than a generic program